MEDI-573, Alone or in Combination with Mammalian Target of Rapamycin Inhibitors, Targets the Insulin-like Growth Factor Pathway in Sarcomas
暂无分享,去创建一个
R. Hollingsworth | C. Morehouse | Jiaqi Huang | Yihong Yao | Haihong Zhong | Cui Chen | S. Breen | C. Fazenbaker | Christine Fazenbaker